Yu Mi Kang

10PUBLICATIONS
60CO-AUTHORS
Nutrigenomics and personalised nutritionMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 20, 2026
Beyond GLP1: modulating multiple nutrient-stimulated hormone pathways to reduce cardiovascular risk.

|Mar 30, 2026
Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Nicholas A Marston, Brian A Bergmark, Thomas A Prohaska

|Feb 27, 2026
Dose-Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting.

Michael A Nauck, Viktoria Punov, Yu Mi Kang

|Jun 22, 2025
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial.

Yu Mi Kang, Robert P Giugliano, Xinhui Ran

|May 09, 2025
Glucagon-like peptide-1 receptor agonists lower risk of cardiovascular and non-cardiovascular mortality: A meta-analysis of eleven cardiovascular outcome trials.

Yu Mi Kang, Erin A Bohula, A Michael Lincoff

|Apr 11, 2025
Comparative efficacy and tolerability of currently approved incretin mimetics: A systematic analysis of placebo-controlled clinical trials.

Yu Mi Kang, Viktoria Punov, Soo Lim

Pageof 2

Frequent Collaborators

3 joint publications

Michael A Nauck

3 joint publications

Marc S Sabatine

2 joint publications

Chang Hee Jung

2 joint publications

Soo Lim